Improving hepatitis b care in the US— A case for a new “ryan white” program

Jonathan D Alpern, Thomas M. Leventhal, Nathan C Bahr

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic hepatitis B infection is common in the United States, yet only a minority of eligible people are screened, vaccinated, and receive treatment. Th e Ryan White HIV/AIDS program has been a key tool for ensuring that socioeconomically disadvantaged HIV-infected patients have access to care. Many of the same disease and patient attributes that make the Ryan White program necessary and eff ective for HIV exist in chronic hepatitis B. Th us, we believe that the current Ryan White program should be expanded to care for people with hepatitis B under similar regulations. Considering recent changes proposed to the health insurance marketplace, policymakers should strongly consider inclusion of chronic hepatitis B in the safety- net Ryan White Program.

Original languageEnglish (US)
Pages (from-to)1037-1043
Number of pages7
JournalJournal of health care for the poor and underserved
Volume31
Issue number3
StatePublished - Aug 2020

Bibliographical note

Funding Information:
Dr. Bahr is funded by the National Institute of Neurological Diseases and Stroke of the National Institutes of Health, K23 NS110470.

Keywords

  • Chronic hepatitis B
  • Linkage to care
  • Ryan White Program

Fingerprint Dive into the research topics of 'Improving hepatitis b care in the US— A case for a new “ryan white” program'. Together they form a unique fingerprint.

Cite this